about
Medical physics aspects of the synchrotron radiation therapies: Microbeam radiation therapy (MRT) and synchrotron stereotactic radiotherapy (SSRT)Ionization cross section data of nitrogen, methane, and propane for light ions and electrons and their suitability for use in track structure simulations.Beam perturbation characteristics of a 2D transmission silicon diode array, Magic Plate.Initial experiments with gel-water: towards MRI-linac dosimetry and imaging.High resolution entry and exit Monte Carlo dose calculations from a linear accelerator 6 MV beam under the influence of transverse magnetic fields.Assessment of out-of-field absorbed dose and equivalent dose in proton fields.Thermoluminescence solid-state nanodosimetry--the peak 5A/5 dosemeter.Mysteries of LiF TLD response following high ionisation density irradiation: nanodosimetry and track structure theory, dose response and glow curve shapes.Benchmarking and validation of a Geant4-SHADOW Monte Carlo simulation for dose calculations in microbeam radiation therapy.Monte Carlo simulation of the dose response of a novel 2D silicon diode array for use in hybrid MRI-LINAC systems.In vivo dosimetry: trends and prospects for brachytherapy.A novel approach to postmastectomy radiation therapy using scanned proton beams.In vitro investigation of the dose-rate effect on the biological effectiveness of megavoltage X-ray radiation doses.Optimizing dose enhancement with Ta2O5 nanoparticles for synchrotron microbeam activated radiation therapy.Study of the effect of ceramic Ta2O5 nanoparticle distribution on cellular dose enhancement in a kilovoltage photon field.RBE estimation of proton radiation fields using a ΔE-E telescope.Synthesis-Dependent Surface Defects and Morphology of Hematite Nanoparticles and Their Effect on Cytotoxicity in Vitro.First proof of bismuth oxide nanoparticles as efficient radiosensitisers on highly radioresistant cancer cells.Indirect radio-chemo-beta therapy: a targeted approach to increase biological efficiency of x-rays based on energy.Absorbed dose-to-water protocol applied to synchrotron-generated x-rays at very high dose rates.High-resolution fiber-optic dosimeters for microbeam radiation therapy.A 2D silicon detector array for quality assurance in small field dosimetry: DUO.Software platform for simulation of a prototype proton CT scanner.Cerium oxide nanoparticles: influence of the high-Z component revealed on radioresistant 9L cell survival under X-ray irradiation.The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.Comparative evaluation of modern dosimetry techniques near low- and high-density heterogeneities.A new virtual ring-based system matrix generator for iterative image reconstruction in high resolution small volume PET systems.Angular independent silicon detector for dosimetry in external beam radiotherapy.In vivo endorectal dosimetry of prostate tomotherapy using dual MOSkin detectors.Use of a megavoltage electronic portal imaging device to identify prosthetic materials.Monte Carlo study of the potential reduction in out-of-field dose using a patient-specific aperture in pencil beam scanning proton therapy.X-ray microbeam measurements with a high resolution scintillator fibre-optic dosimeter.Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement.Nanodosimetry-based quality factors for radiation protection in space.BrachyView: proof-of-principle of a novel in-body gamma camera for low dose-rate prostate brachytherapy.Normal tissue dose and second cancer risk due to megavoltage fan-beam CT, static tomotherapy and helical tomotherapy in breast radiotherapy.Online in vivo dosimetry in high dose rate prostate brchytherapy with MOSkin detectors: in phantom feasibility study.Ion radiography as a tool for patient set-up and image guided particle therapy: a Monte Carlo study.Proton-impact ionisation cross sections for nanodosimetric track structure simulations.Erratum: "Out-of-field dose equivalents delivered by proton therapy of prostate cancer".
P50
Q28082894-F4C235B4-9356-486D-95CD-A8574DB4641CQ30694941-10673039-A0DC-49B7-B156-14400BDF1C33Q31076256-9C1BBD17-3ED8-4B67-B389-38257B56044DQ31141037-E484AB73-100B-4D7B-8FA9-CAF07F11AF03Q33502287-AA25E371-F73D-44D4-99D4-60F6E77F5525Q33579632-EA2161AC-49FE-41AB-81BF-BC395BDAAFE9Q35025187-174631AB-9F35-4A7A-9089-464E3D9E5074Q35133079-2702C0A5-96FD-47B6-B0FD-CC1DF7BD996AQ35157169-984871CC-6731-4FB7-9F03-28C2D4925744Q35555340-FB982608-DBEE-4158-A53E-FC3DCC54BB32Q35676752-82FD3B4B-9A9C-44EC-BA9D-964DADD2CA87Q38338104-A4F4AD45-1EF5-4EA0-A00E-D903CBB1C844Q38678743-1B64A6BE-936B-460B-B115-0413191830B1Q38730008-EC96ACE0-87F6-4A98-BE91-2FCE2B6ECB1DQ38743814-A89B6497-B1FC-48F7-B312-C4A7C6F60FFEQ38774785-41231E7C-6879-418C-BAA0-E1ABDAB579C2Q38793890-25EB93E4-BDF9-46A7-81D9-4D5666D2C4C3Q38807992-9E152D4D-420E-4403-B6BD-FE889EF7FEE8Q38832526-53C5EF4D-09B6-4119-93EA-AE19AF88EE8AQ38846386-3101448C-A210-43EF-BC08-155C80FFE63CQ38907579-3214D98D-E8EF-4741-B07A-5D7B7E981B98Q38984085-3B2ED413-47FB-48E4-AADD-F171553BC5BAQ39017044-2D810C57-6F84-4327-9373-947DE4C98F48Q39183261-9EF661EE-FD6A-4353-813E-E0CB46690CBAQ39298668-A49A4FED-F1BD-4BAC-AB0C-785A97B6874DQ40176770-78947914-E49F-42E8-95B2-1FC320429FD0Q40608995-7F8FF2AC-8FE5-4F16-9E67-858DB8178800Q40670452-43A594F4-3F78-413B-880E-7DDF2F1F724CQ40807315-C69BB91E-3D52-41A0-875C-CDF76495EF13Q41598927-3F96F196-3A3E-4A6F-A6D5-62780147F465Q41968411-F94DED2E-6934-4A8D-94BE-764318C49D1AQ42115304-2068D4B3-6853-45E6-A815-EBA6A0E89FCEQ42277882-C0B6F13B-22D1-457E-8F93-AF50530547E1Q44210040-3FED2362-E714-4F14-820C-8D0013E1E587Q44404801-E4EB373B-660F-4365-991B-97B16A5897CAQ44538502-C8D2A5D0-AB2B-44B7-869C-376D4934B2C7Q44826156-07105F2D-F879-48C9-B391-953102C3242DQ45122554-1B5F9F6F-F281-4976-8F8B-81973C8B7A8FQ46295915-D46F7639-F413-4AF1-9F8B-50AAFE1C69B4Q46650660-63CE2B5A-0388-4152-AF5C-3C1A22C0D2A8
P50
description
researcher ORCID ID = 0000-0001-5116-6308
@en
wetenschapper
@nl
name
Anatoly Rosenfeld
@ast
Anatoly Rosenfeld
@en
Anatoly Rosenfeld
@es
Anatoly Rosenfeld
@nl
type
label
Anatoly Rosenfeld
@ast
Anatoly Rosenfeld
@en
Anatoly Rosenfeld
@es
Anatoly Rosenfeld
@nl
prefLabel
Anatoly Rosenfeld
@ast
Anatoly Rosenfeld
@en
Anatoly Rosenfeld
@es
Anatoly Rosenfeld
@nl
P1153
7201932364
P31
P496
0000-0001-5116-6308